Merck & Co Inc
Performance History
| Key Stats | |
|---|---|
| Open | $100.28 |
| Prev. Close | $100.18 |
| EPS | 1.80 |
| Dividend | $2.88 |
| Next Earnings Date | Aug 1, 2023 |
| Dividend Yield % | 2.91% |
| Market Cap | $256.26B |
| PE Ratio | 56.18 |
| low | high | |
|---|---|---|
| Day Range | 99.80 | 101.17 |
| 52 Week Range | 99.14 | 119.65 |
| Ratios | |
|---|---|
| P/B Ratio | 6.15 |
| Revenue | $59.31B |
| Operating M. % | 36.49% |
| Earnings | $4.62B |
| Earnings Growth % | 46.10% |
| EBITDA Margin % | 21.81% |
| ROE % | 10.77% |
| EPS | 1.80 |
Score Breakdown
All Score (79 / 100) is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.
| MRK | Market | |
|---|---|---|
| Value | 34 | 42 |
| Quality | 83 | 46 |
| Ownership | 92 | 39 |
| Growth | 78 | 44 |
| Dividends | 46 | 32 |
All Score (79 / 100) is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.
Financial Forecast
AI Price Prediction
Analyst Ratings
Correlated Companies
About Merck & Co Inc (MRK)
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. It has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics LP; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
- ISN
- -
- Sector
- Healthcare
- Industry
- Drug Manufacturers—General
- CEO
- Mr. Robert M. Davis J.D.
- Headquarters
- Rahway
- Employees
- 67000
Keep an eye on Merck & Co Inc
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
News
Sign up for our newsletter
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.